Heart Failure
Clinical Indications and Science Learning Series
Valvular Heart Disease and Cardiomyopathies
Advertisement
Episodes
SMART Revisited: Contemporary Evidence for Treating AS in Patients With Small Annuli
9 min.
Aortic Valve Disease in Patients with Heart Failure: The HF Physician's Approach: GDMT - Give the Darn Medicines a Try!
12 min.
Aortic Valve Disease in Patients with Heart Failure: The Percutaneous Approach: One Step at a Time…
7 min.
Aortic Valve Disease in Patients with Heart Failure: The Surgical Approach: Fix 'Em All At Once!
6 min.
Lessons From AVR Studies in Patients With Aortic Stenosis and Heart Failure
13 min.
Putting It All Together: A Case of TTVR
12 min.
Pills, Drips and Pumps: Management of Volume Status and RV Dysfunction Before and After TTVI
16 min.
TTVI Trial Updates
9 min.
Strategies to Reduce the Burden of Residual MACE After mTEER in Patients With FMR
8 min.
Cardiomechanics in Patients Undergoing mTEER: Insights From PV Analysis
9 min.
How Do I Decide on Choice of Mechanical Circulatory Support in MI: A Personal Perspective
14 min.
How Great if True: My Futuristic View in How GLP-1 Agonist Will Continue Expanding Its Therapeutic Reach
18 min.
Worsening Heart Failure: How to Identify, How to Treat
10 min.
How to Recognize Amyloidosis and the Consequences of the Disease?
19 min.
Is there Still a Role for Surgery in HCM?
8 min.
Myosin Inhibitors and Novel Medical Therapies for HCM
13 min.
A Clinical Approach to Genetics in Hypertrophic Cardiomyopathy
13 min.
RV Function and the Pulmonary Circulation: Physiological Insights Influencing Clinical Decision Making in TR Treatment
9 min.
Case Resolution: TTVI in the Failing Right Heart
9 min.
TTVI in in the Failing Right Heart
16 min.
Case Presentation: TTVI in the Failing Right Heart
3 min.
Will New VHD Screening Methods Address or Exacerbate Healthcare Disparities?
15 min.
The Landscape of Novel Methods to Screen for VHD
11 min.
Screening for VHD: Beyond Proof of Concept to Implementation and Scaling
17 min.
Designing Trials to Assess the Effectiveness of New VHD Screening Strategies
15 min.
The Importance of Patient Reported Outcomes in VHD
12 min.
Diversity and Under Represented Populations in VHD: Focusing on Real Solutions
17 min.
Using Real-world Data in VHD: Sources, Successes, and Failures
16 min.
Secondary Mitral Regurgitation: Challenges and Limitations of Current Technology
8 min.
Echocardiographic Speckle Strain Imaging and Valvular Heart Disease Outcomes
13 min.
Unleashing the Potential of CMR and CT: Myocardial Risk Stratification for VHD
13 min.
Overview of the Role of Artificial Intelligence and Machine Learning for VHD Detection
16 min.
Secondary MR and GDMT Titration Before M-TEER in the Real-world
17 min.
Atrial FMR: The Heart Failure Perspective – Epidemiology and Medical Management
16 min.
Case Presentation: Aortic Stenosis and Dyspnea – What Do We Call It? Is It HFpEF OR Is It the Valve?
4 min.
Requirements for GDMT in UPSTREAM AVR Clinical Trials in (1) Preserved EF or (2) Reduced EF Patients
18 min.
Medical Management Post AVR
17 min.
Current Treatment Options for HFrEF Patients Failing GDMT
8 min.
Use of a Novel Intra-Aortic Entrainment Pump for a Patient With Restrictive Cardiomyopathy and Recurrent Cardiorenal Syndrome
8 min.
Alternative Advanced Therapy: Case of Cardiac Contractility Modulation in Stage D Ischemic Cardiomyopathy
14 min.
Neuromodulation by Atrioventricular Interval Modulation (AVIM) Therapy
7 min.
In-vivo Pressure-Volume Reconstructions to Evaluate Immediate Changes in Left Ventricular Cardiomechanics Following Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis
9 min.
Interventional Procedures in High-Risk Decompensated Valvular Heart Disease
11 min.
M-TEER in Decompensated Heart Failure: Indications, Timing, and Challenges
19 min.
Moderate AS in HFrEF: Time to Treat Is Now
15 min.
Assessing the Risk of LV Failure After TAVR
15 min.
Mitral Transcatheter Edge-to-Edge Repair for Secondary MR in the Management of HFrEF: Where Does It Fit in?
15 min.
Atrial Secondary MR or TR in HFpEF: How to Treat
14 min.
No, It's never too late for TTVI !
16 min.
Yes, It can be already too late for TTVI !
5 min.
When Is It Too Late for Mitral-TEER?
13 min.
The Role of RV and RV-PA Coupling in Outcomes Following Atrioventricular-Valve Interventions
16 min.
Pillars of Heart Failure Management in Functional Atrioventricular-Valves Disease
16 min.
Percutaneous Closure of Aortic to Right Ventricle Fistula After Transcatheter Aortic Valve Replacement: 3D Printing Saved the Day
13 min.
Tinkering the Ticker: TandemHeart to TAVR
10 min.
TMVR Clinical Trials: Ready for Prime Time or Stuck in the Mud?
11 min.
New Approaches to MAC Therapy
12 min.
5-Year COAPT Outcomes With MitraClip in FMR
9 min.
Overview of Transcatheter Devices for FMR
9 min.
Atrial and Ventricular Functional MR: Treatment Implications
9 min.
Treatment Algorithms: Matching Devices With Anatomy and Clinical Factors
9 min.
TR in the Modern Era: Natural History, Pathoanatomy, and Imaging
9 min.
RV Mechanics and RV-PA Coupling in TR
9 min.
TR Management in the Setting of MR: Lessons From Surgical Experiences
12 min.
A Comprehensive Overview of New Transcatheter TR Therapies
8 min.
AS Reclassified According to Valve Function and Cardiac Disease
11 min.
Recurrent Heart Failure After AVR: Causes and Treatment
8 min.
Low Flow - Low Gradient AS and Assessing Myocardial Reserve
15 min.
Managing Heart Failure in AS With Multivalve Disease
10 min.
Moderate AS With Heart Failure: UNLOAD and Beyond
9 min.
High Surgical Risk Aortic Regurgitation: New TAVR Alternatives
11 min.
Tricuspid Valve Interventions: When Is the RV Too Sick?
8 min.
Acute MR With MCS/TEER
6 min.
Aortic Stenosis With Acute LV Unloading With Septostomy
13 min.
Aortic Stenosis TAVR With Annular Rupture/ Tamponade
14 min.
Cardiogenic Shock: ECMO Supported TAVR
12 min.
Prognostic Value of Tricuspid Valve Gradient After Transcatheter Edge-To-Edge Repair: Insights from the TriValve Registry
9 min.
Applications of Gene Therapy in Cardiomyopathies
14 min.
Case Resolution: Advanced Heart Failure Patient With Mitral Regurgitation: Edge-to-Edge Repair Versus Transplant/LVAD
1 min.
Case Presentation: Advanced Heart Failure Patient With Mitral Regurgitation: Edge-to-Edge Repair Versus Transplant/LVAD - Tx/VAD
5 min.
Case Presentation: Advanced Heart Failure Patient With Mitral Regurgitation: Edge-to-Edge Repair Versus Transplant/LVAD - Mitraclip!
5 min.
Case Presentation: Advanced Heart Failure Patient With Mitral Regurgitation: Edge-to-Edge Repair Versus Transplant/LVAD
3 min.
Latest on Mitra/Tx/LVAD
5 min.
Case Resolution: Management of Advanced HF in a Patient with Severe Secondary MR
16 min.
COUNTERPOINT: Escalate to LVAD/Transplant is the Right Choice!
6 min.
Case Presentation: Management of Advanced HF in a Patient with Severe Secondary MR
5 min.
TCT 650: Transcatheter Edge-to-Edge Valve Repair for Torrential Atrioventricular Valve Regurgitation in a Patient With Left Isomerism
5 min.
TCT 740: Transcatheter solution for a massive tricuspid regurgitation and refractory right side heart failure in a patient with a previous cardiac transplantation.
6 min.
TCT 639: Technically Challenging Transcatheter Tricuspid Valve in Valve Procedure for Right Heart Failure
5 min.